Tokio Marine Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Hold
6,428
0.04% 317
2026
Q1
$1.18M Buy
6,428
+859
+15% +$158K 0.04% 328
2025
Q4
$980K Hold
5,569
0.03% 361
2025
Q3
$780K Hold
5,569
0.03% 402
2025
Q2
$699K Buy
5,569
+396
+8% +$49.3K 0.03% 414
2025
Q1
$708K Buy
5,173
+901
+21% +$129K 0.03% 399
2024
Q4
$653K Hold
4,272
0.02% 410
2024
Q3
$828K Buy
4,272
+754
+21% +$158K 0.04% 330
2024
Q2
$816K Buy
3,518
+110
+3% +$23.9K 0.04% 309
2024
Q1
$735K Buy
3,408
+465
+16% +$109K 0.04% 331
2023
Q4
$762K Hold
2,943
0.04% 306
2023
Q3
$756K Hold
2,943
0.05% 267
2023
Q2
$838K Buy
2,943
+174
+6% +$51.8K 0.05% 240
2023
Q1
$770K Buy
2,769
+243
+10% +$67.2K 0.05% 244
2022
Q4
$700K Buy
2,526
+309
+14% +$87.3K 0.05% 236
2022
Q3
$592K Buy
2,217
+285
+15% +$60.5K 0.05% 231
2022
Q2
$394K Buy
1,932
+185
+11% +$37.8K 0.03% 306
2022
Q1
$368K Sell
1,747
-58
-3% -$12.6K 0.03% 332
2021
Q4
$433K Buy
1,805
+267
+17% +$68.7K 0.03% 280
2021
Q3
$435K Buy
1,538
+176
+13% +$57.7K 0.04% 261
2021
Q2
$472K Buy
1,362
+279
+26% +$84.5K 0.04% 225
2021
Q1
$303K Sell
1,083
-1,395
-56% -$376K 0.03% 283
2020
Q4
$607K Buy
2,478
+70
+3% +$18.1K 0.07% 158
2020
Q3
$683K Buy
2,408
+1,500
+165% +$418K 0.09% 122
2020
Q2
$243K Buy
908
+53
+6% +$15.9K 0.03% 219
2020
Q1
$271K Buy
855
+171
+25% +$51.9K 0.05% 171
2019
Q4
$203K Buy
+684
New +$190K 0.03% 234
2019
Q1
Sell
-13,016
Closed -$3.92M 211
2018
Q4
$3.92M Buy
13,016
+39
+0.3% +$12.4K 0.79% 34
2018
Q3
$4.58M Sell
12,977
-40
-0.3% -$13.8K 0.8% 34
2018
Q2
$3.78M Buy
13,017
+2
+0% +$562 0.69% 39
2018
Q1
$3.56M Buy
13,015
+4,819
+59% +$1.5M 0.63% 46
2017
Q4
$2.61M Sell
8,196
-453
-5% -$145K 0.39% 64
2017
Q3
$2.71M Sell
8,649
-706
-8% -$209K 0.41% 70
2017
Q2
$2.54M Sell
9,355
-1,160
-11% -$307K 0.36% 75
2017
Q1
$2.88M Sell
10,515
-5,055
-32% -$1.43M 0.38% 72
2016
Q4
$4.42M Sell
15,570
-5,823
-27% -$1.73M 0.51% 60
2016
Q3
$6.7M Sell
21,393
-2,805
-12% -$831K 0.73% 41
2016
Q2
$5.85M Sell
24,198
-242
-1% -$63.8K 0.6% 48
2016
Q1
$6.36M Buy
24,440
+1,056
+5% +$279K 0.64% 43
2015
Q4
$7.16M Sell
23,384
-3,776
-14% -$1.09M 0.79% 34
2015
Q3
$7.93M Buy
27,160
+2,773
+11% +$916K 0.83% 30
2015
Q2
$9.85M Buy
24,387
+1,618
+7% +$649K 0.97% 24
2015
Q1
$9.61M Sell
22,769
-5,816
-20% -$2.29M 0.89% 28
2014
Q4
$9.7M Sell
28,585
-14,285
-33% -$4.62M 0.84% 28
2014
Q3
$14.2M Sell
42,870
-2,382
-5% -$785K 1.03% 12
2014
Q2
$14.3M Buy
45,252
+18,819
+71% +$5.66M 0.97% 17
2014
Q1
$8.09M Sell
26,433
-871
-3% -$276K 0.52% 45
2013
Q4
$7.63M Sell
27,304
-1,436
-5% -$371K 0.47% 49
2013
Q3
$6.92M Sell
28,740
-3,511
-11% -$786K 0.44% 53
2013
Q2
$6.94M Buy
+32,251
New +$6.89M 0.44% 49

Other funds holding BIIB

Tokio Marine Asset Management's BIIB Position: Q2 2026 in Review

Tokio Marine Asset Management held its Biogen (BIIB) position steady in Q2 2026 at 6,428 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #317.

Tokio Marine Asset Management first reported a position in BIIB in Q2 2013 and has held it in 50 quarters since. The position peaked at $14.3M in Q2 2014. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Tokio Marine Asset Management held 6,428 shares of Biogen worth $1.39M as of Q2 2026.
  • Tokio Marine Asset Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.04% of Tokio Marine Asset Management's portfolio in Q2 2026, its #317 holding.
  • Tokio Marine Asset Management first reported a position in Biogen in Q2 2013 and has held it in 50 quarters since.
  • Tokio Marine Asset Management's Biogen position peaked at $14.3M in Q2 2014.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.